Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Charles River Laboratories Intl. Inc (CRL) vs Eaton Corporation plc (ETN) Price & Performance

Charles River Laboratories Intl. IncTrade
Eaton Corporation plcTrade

Price performance (Past 24H)

Key statistics

Charles River Laboratories Intl. Inc vs Eaton Corporation plc — how do they compare? Charles River Laboratories Intl. Inc trades at $287.02 (market cap $13.46B), while Eaton Corporation plc trades at $461.69 (market cap $172.82B). The key difference: Eaton Corporation plc is far larger — about 12.8× Charles River Laboratories Intl. Inc's market cap, and Eaton Corporation plc pays a 0.99% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.

CRLETN
Market Cap
$13.46B$172.82B
Sector
HealthTechnology
52-Week High
$282.00$459.29
52-Week Low
$145.57$315.82
Enterprise Value
$16.30B$193.45B
Dividend Yield
0.99%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Charles River Laboratories Intl. Inc

Charles River Laboratories (CRL) trades at $286.36, up 3.38% today and near its 52-week high of $277.07. The stock shows strong technical momentum with bullish moving averages and has beaten earnings estimates for three consecutive quarters. Recent Q2 2026 results exceeded expectations with EPS of $3.02 versus $2.77 estimate, driving positive sentiment. However, valuation metrics remain elevated with P/E at 684.85 and negative profitability margins.

While technical indicators and analyst consensus (72% buy ratings) support near-term upside, fundamental concerns persist with negative net income margin (-5.96%) and ROE (-7.7%). The stock faces execution risks in maintaining earnings momentum amid competitive pressures. Current price exceeds consensus target of $277.29, suggesting limited near-term upside potential despite positive business inflection.

Eaton Corporation plc

Eaton Corporation (ETN) trades at $463.70, up 4.21% over the past 24 hours, near its 52-week high. The stock shows strong technical momentum with bullish moving averages and is approaching resistance at $467. Fundamentally, the company reported three consecutive quarterly earnings beats, with Q2 2026 EPS of $3.15 beating estimates of $3.07, and raised its full-year 2026 outlook. Revenue growth is robust, supported by surging data-center demand and a $7 million U.S. Air Force contract for grid security announced on August 6, 2026.

The outlook remains positive given Eaton's exposure to AI-driven power infrastructure spending, but the stock's premium valuation (P/E of 45.31) poses a risk if growth moderates. Analyst consensus is strongly bullish with a $499.75 price target, though investors should monitor execution risks and macroeconomic pressures that could impact the industrial sector.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Charles River Laboratories Intl. Inc

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Read more on CRL

About Eaton Corporation plc

Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.

Read more on ETN